MedCityNewsTempus Unveils a Standalone Tool for Structuring Clinical Data at ScaleDec 11, 2017Media CoverageRelated contentTempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral RegurgitationTempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model